Loading...
Japan Tissue Engineering Co., Ltd.
7774.T•JPX
Healthcare
Biotechnology
¥581.00
¥-7.00(-1.19%)
Japan Tissue Engineering Co., Ltd. (7774.T) Financial Performance & Income Statement Overview
Review Japan Tissue Engineering Co., Ltd. (7774.T) income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
-2.34%
↓ 2.34%
Operating Income Growth
-264.92%
↓ 264.92%
Net Income Growth
-278.32%
↓ 278.32%
Operating Cash Flow Growth
-154.12%
↓ 154.12%
Operating Margin
-7.44%
↓ 7.44%
Gross Margin
61.59%
↑ 61.59%
Net Profit Margin
-10.41%
↓ 10.41%
ROE
-4.39%
↓ 4.39%
ROIC
-3.11%
↓ 3.11%
Japan Tissue Engineering Co., Ltd. (7774.T) Income Statement & Financial Overview
Review Japan Tissue Engineering Co., Ltd. 7774.T income statement with detailed quarterly and annual figures.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $749.06M | $545.42M | $719.55M | $442.31M |
| Cost of Revenue | $237.83M | $215.41M | $295.08M | $195.22M |
| Gross Profit | $511.23M | $330.002M | $424.46M | $247.09M |
| Gross Profit Ratio | $0.68 | $0.61 | $0.59 | $0.56 |
| R&D Expenses | $334.39M | -$91.91M | $210.001M | $54.24M |
| SG&A Expenses | $27.38M | $544.83M | $228.53M | $440.35M |
| Operating Expenses | $361.77M | $454.81M | $438.53M | $440.35M |
| Total Costs & Expenses | $599.60M | $670.22M | $733.62M | $635.57M |
| Interest Income | $1.57M | $532000.00 | $279000.00 | $225000.00 |
| Interest Expense | $0.00 | $0.00 | $0.00 | $0.00 |
| Depreciation & Amortization | $39.60M | $33.50M | $40.04M | $193.25M |
| EBITDA | $191.22M | -$90.30M | $26.51M | -$153.82M |
| EBITDA Ratio | $0.26 | -$0.17 | $0.04 | -$0.35 |
| Operating Income | $149.46M | -$124.80M | -$14.07M | -$193.25M |
| Operating Income Ratio | $0.20 | -$0.23 | -$0.02 | -$0.44 |
| Other Income/Expenses (Net) | -$53.80M | $1.66M | $538000.00 | $386000.00 |
| Income Before Tax | $95.66M | -$123.14M | -$13.53M | -$192.87M |
| Income Before Tax Ratio | $0.13 | -$0.23 | -$0.02 | -$0.44 |
| Income Tax Expense | $907000.00 | $1.91M | $641000.00 | $18.27M |
| Net Income | $94.75M | -$125.05M | -$14.18M | -$211.14M |
| Net Income Ratio | $0.13 | -$0.23 | -$0.02 | -$0.48 |
| EPS | $2.34 | -$3.08 | -$0.35 | -$5.20 |
| Diluted EPS | $2.34 | -$3.08 | -$0.35 | -$5.20 |
| Weighted Avg Shares Outstanding | $40.61M | $40.61M | $40.60M | $40.60M |
| Weighted Avg Shares Outstanding (Diluted) | $40.61M | $40.61M | $40.60M | $40.60M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan